ArticleThe Journal of allergy and clinical immunology2021

PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment.

Elliot Israel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.